Literature DB >> 18239426

Statistically designed enzymatic hydrolysis for optimized production of icariside II as a novel melanogenesis inhibitor.

Jun-Seong Park1, Hye Yoon Park, Ho-Sik Rho, Soomi Ahn, Duck Hee Kim, Ih Seop Chang.   

Abstract

Three kinds of prenylated flavonols, icariside I, icariside II, and icaritin, were isolated from an icariin hydrolysate and their effects on melanogenesis evaluated based on mushroom tyrosinase inhibition and quantifying the melanin contents in melanocytes. Although none of the compounds had an effect on tyrosinase activity, icariside II and icaritin both effectively inhibited the melanin contents with an IC50 of 10.53 and 11.13 MM, respectively. Whereas icariside II was obtained from a reaction with beta-glucosidase and cellulase, the icariin was not completely converted into icariside II. Thus, for the high-purity production of icariside II, the reaction was optimized using the response surface methodology, where an enzyme concentration of 5.0 mg/ml, pH 7, 37.5 degrees C;, and 8 h reaction time were selected as the central conditions for the central composite design (CCD) for the enzymatic hydrolysis of icariin into icariside II using cellulase. Empirical models were developed to describe the relationships between the operating factors and the response (icariside II yield). A statistical analysis indicated that all four factors had a significant effect (p<0.01) on the icariside II production. The coefficient of determination (R2) was good for the model (0.9853), and the optimum production conditions for icariside II was an enzyme concentration of 7.5 mg/ml, pH 5, 50 degrees C, and 12 h reaction time. A good agreement between the predicted and experimental data under the designed optimal conditions confirmed the usefulness of the model. A laboratory pilot scale was also successful.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239426

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  8 in total

1.  Optimized Biotransformation of Icariin into Icariside II by β-Glucosidase from Trichoderma viride Using Central Composite Design Method.

Authors:  Tao Cheng; Jun Yang; Tong Zhang; Yi-Shun Yang; Yue Ding
Journal:  Biomed Res Int       Date:  2016-02-14       Impact factor: 3.411

2.  Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats.

Authors:  Lin Wang; Yongde Xu; Huixi Li; Hongen Lei; Ruili Guan; Zhezhu Gao; Zhongcheng Xin
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

3.  Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease.

Authors:  Jiansheng Li; Peng Zhao; Ya Li; Yange Tian; Yonghua Wang
Journal:  Sci Rep       Date:  2015-10-15       Impact factor: 4.379

Review 4.  Bioavailability Improvement Strategies for Icariin and Its Derivates: A Review.

Authors:  Róbert Szabó; Csaba Pál Rácz; Francisc Vasile Dulf
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

5.  Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer.

Authors:  Chen Hong; Lili Yang; Yifan Zhang; Yiming Li; Huali Wu
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

6.  Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis--an in vitro efficacy study.

Authors:  Dong Yao; Xin-Hui Xie; Xin-Luan Wang; Chao Wan; Yuk-Wai Lee; Shi-Hui Chen; Duan-Qing Pei; Yi-Xiang Wang; Gang Li; Ling Qin
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

7.  Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.

Authors:  Peng Zhao; Jiansheng Li; Ya Li; Yange Tian; Yonghua Wang; Chunli Zheng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-07

8.  Synthesis of prenylated flavonols and their potents as estrogen receptor modulator.

Authors:  Zhenru Tao; Juan Liu; Yueming Jiang; Liang Gong; Bao Yang
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.